PTC Therapeutics Inc. (PTCT)
NASDAQ: PTCT
· Real-Time Price · USD
51.79
0.53 (1.03%)
At close: Jun 16, 2025, 3:59 PM
51.62
-0.33%
After-hours: Jun 16, 2025, 05:38 PM EDT
1.03% (1D)
| Bid | 40 |
| Market Cap | 4.1B |
| Revenue (ttm) | 1.77B |
| Net Income (ttm) | 594.84M |
| EPS (ttm) | 6.51 |
| PE Ratio (ttm) | 7.96 |
| Forward PE | -21.61 |
| Analyst | Buy |
| Ask | 53.29 |
| Volume | 776,052 |
| Avg. Volume (20D) | 1,221,146 |
| Open | 51.24 |
| Previous Close | 51.26 |
| Day's Range | 50.16 - 51.95 |
| 52-Week Range | 28.72 - 58.38 |
| Beta | 0.51 |
About PTCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PTCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PTCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
PTC Therapeutics shares are trading higher after t...
Unlock content with
Pro Subscription
1 month ago
PTC Therapeutics shares are trading lower. The company announced results from the Phase 2 PIVOT-HD study of PTC518 in Stage 2 and Stage 3 Huntington's disease patients.
1 month ago · accessnewswire.com
Lost Money on PTC Therapeutics, Inc. (PTCT)? Possible Fraud - Contact Levi & Korsinsky TodayNEW YORK, NY / ACCESS Newswire / May 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of PTC Therapeutics, Inc. ("PTC Therapeutics, Inc.") (NASDAQ:PTCT) concerning...